Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively

The Delhi High Court has provided relief to pharma companies like Glenmark Pharmaceuticals and Zuventus Healthcare, ruling that the ban on fixed-dose combinations for children under four will be applied prospectively. The court directed companies to issue advisories to doctors and publish notices in national newspapers, informing that the drugs should not be prescribed for children below four years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Z2Wn643
via IFTTT